Modulation of oestrogen excretion profiles by adjuvant chemotherapy in pre- and postmenopausal breast cancer

This publication has 29 references indexed in Scilit:

• ADJUVANT CHEMOTHERAPY OF BREAST CANCER: REALITY, HOPE, HAZARD?
  The Lancet, 1981
• Pituitary-ovarian function in breast cancer patients on adjuvant chemoimmunotherapy
  Cancer, 1978
• The CMF program for operable breast cancer with positive axillary nodes:Updated analysis on the disease-free interval, site of relapse and drug tolerance
  Cancer, 1977
• OVARIAN FUNCTION IN PATIENTS RECEIVING ADJUVANT CHEMOTHERAPY FOR BREAST CANCER
  The Lancet, 1977
• Cyclophosphamide-induced ovarian failure and its therapeutic significance in patients with breast cancer
  Cancer, 1977
• STERILITY AND CYCLOPHOSPHAMIDE
  The Lancet, 1972
• Alkylating agents and human spermatogenesis
  Published by American Medical Association (AMA) ,1971
• Multiple late complications of therapy with cyclophosphamide, including ovarian destruction
  The American Journal of Medicine, 1971
• Long‐term cyclophosphamide therapy in rheumatoid arthritis
  Arthritis & Rheumatism, 1968
• Production of ovarian dysgenesis in the rat and human by busulphan
  American Journal of Obstetrics and Gynecology, 1964